22 Stocks Moving in Thursday’s Pre-Market Session
Today, 3:25 AM
Gainers
Good Works Acquisition Corp. (NASDAQ: GWAC) rose 29.8% to $13.01 in pre-market trading. Good Works Acquisition and Cipher Mining reported shareholder approval of business combination.
Credit Suisse Maintains Outperform on Ascendis Pharma, Raises Price Target to $185
Today, 3:25 AM
Credit Suisse analyst Tiago Fauth maintains Ascendis Pharma (NASDAQ:ASND) with a Outperform and raises the price target from $178 to $185.
SVB Leerink Maintains Outperform on Ascendis Pharma, Raises Price Target to $182
Today, 3:25 AM
SVB Leerink analyst Joseph Schwartz maintains Ascendis Pharma (NASDAQ:ASND) with a Outperform and raises the price target from $178 to $182.
Ascendis Pharma A/S Announces U.S. Food and Drug Administration Approval of SKYTROFA® (lonapegsomatropin-tcgd), the First Once-weekly Treatment for Pediatric Growth Hormone Deficiency
Today, 3:25 AM
SKYTROFA, the first FDA approved treatment utilizing TransCon™ technology, is a long-acting prodrug of somatropin that releases the same somatropin used in daily therapies –
- Once weekly
The Daily Biotech Pulse: Lilly Strikes $1.6B R&D Collaboration, FSD Pulls Plug On COVID-19 Program, Cassava Sinks On Questions About Alzheimer’s Drug
Today, 3:25 AM
ere's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs Aug. 24)
Earnings Scheduled For August 25, 2021
Today, 3:25 AM
Companies Reporting Before The Bell
• Jiayin Gr (NASDAQ:JFIN) is projected to report quarterly earnings at $0.21 per share on revenue of $54.80 million.
The Week Ahead In Biotech: Cara FDA Decision, Ascendis Earnings, Aileron Data Presentation And More
Today, 3:25 AM
Biotech stocks swayed back and forth before ending the week lower. With earnings news dying down and an empty initial public offerings calendar, it was broader market cues, clinical readouts and regulatory actions that moved stocks during the week.
Hookipa Shares Move Higher Following Circulation Of TipRanks Article ‘3 “Strong Buy” Stocks Trading at Rock-Bottom Prices’; BioXcel, Ascendis Shares Also Mentioned
Today, 3:25 AM
https://www.tipranks.com/news/article/3-strong-buy-stocks-trading-at-rock-bottom-prices-2